课题基金 / 基金详情

项目摘要

项目成果

MARTIN E DORF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): TNFa and IL-1p are proinflammatory mediators that induce a storm of chemokines and cytokines. They are thought to be responsible for prolonging production of inflammatory mediators in multiple chronic autoimmune and infectious diseases. We propose to investigate the mechanisms responsible for regulating responses to these prototype cytokines. Specifically, we will define the phosphatase requirements for controlling TNF and IL-1-mediated NF-KB activation. An RNAi approach will be used with a NF-KB-luciferase reporter. 500 siRNA constructs have been prepared and screened for basal and TNF-mediated signaling in SV40 large T antigen immortalized and primary cell cultures. Preliminary data demonstrate the effectiveness of this strategy. 19 phosphatase genes were identified in our initial screens. 10 of 19 genes were not previously associated with NF-KB signaling. The proposal lists three specific Aims. The first is to identify phosphatases involved in TNF and IL-1 signaling. This Aim details the methodology required to validate our initial findings, and applies our RNAi strategy to the study of IL-1 signaling. The function of each phosphatase gene associated with NF-KB signaling will be confirmed by over-expression. The second Aim investigates the direct and indirect targets for the phosphatases identified in Aim #1. We define points (kB degradation and nuclear translocation) in the signaling pathway above or below which the phosphatases are likely to operate. Co-immunoprecipitation of myc-tagged phosphatase components will be used to identify physical associations among NF-KB components and phosphatases. The subunits comprising the active PP1 and PP2A holoenzymes will be characterized. We also examine dephosphorylation of suspected target proteins, including TRAF2 and the p65 subunit of NF-KB. We then detail the mechanisms of action for a few phosphatases. The third Aim focuses on the ability of phosphatases to regulate transcription of endogenous genes. Preliminary data demonstrate the differential effects of phosphatase genes on regulation of chemokine and cytokine transcription. These studies will be extended to additional phosphatase genes, and we will examine transcriptional regulation of a selected series of NF-KB-dependent genes involved in the inflammatory process. In summary, the proposed experiments will provide insights into the role of phosphatases in controlling NF-KB-mediated signaling. We will also evaluate the impact of individual genes in controlling transcription of endogenous inflammatory mediators.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.molcel.2008.11.023
发表时间: 2009-01-16
期刊: MOLECULAR CELL
影响因子: 16
作者: [Li, Shitao, Wang, Lingyan, Dorf, Martin E.]
通讯作者: Dorf, Martin E.
DOI: 10.1016/j.jneuroim.2009.07.007
发表时间: 2009-10-30
期刊: Journal of neuroimmunology
影响因子: 3.3
作者: [Abromson-Leeman S, Bronson RT, Dorf ME]
通讯作者: Dorf ME
DOI: 10.1371/journal.pone.0043756
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Wang L, Li S, Dorf ME]
通讯作者: Dorf ME
DOI: 10.1016/j.immuni.2011.06.014
发表时间: 2011-09-23
期刊: Immunity
影响因子: 32.4
作者: [Li S, Wang L, Berman M, Kong YY, Dorf ME]
通讯作者: Dorf ME
Interferon-induced IFITM recruitment of ZMPSTE24 blocks viral endocytic entry
  • 批准号:
    9317424
  • 项目类别:
  • 资助金额:
    $51.79万
  • 财政年份:
    2016
  • 负责人:
    MARTIN E DORF
  • 依托单位:
Signaling Networks Controlling Innate Immune Responses to Cytosolic DNA
  • 批准号:
    8424872
  • 项目类别:
  • 资助金额:
    $21.19万
  • 财政年份:
    2012
  • 负责人:
    MARTIN E DORF
  • 依托单位:
Signaling Networks Controlling Innate Immune Responses to Cytosolic DNA
  • 批准号:
    8283811
  • 项目类别:
  • 资助金额:
    $25.43万
  • 财政年份:
    2012
  • 负责人:
    MARTIN E DORF
  • 依托单位:
Role of TBK1 polyubiquitination in innate antiviral immunity
  • 批准号:
    8108823
  • 项目类别:
  • 资助金额:
    $54.05万
  • 财政年份:
    2011
  • 负责人:
    MARTIN E DORF
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: